In this recording session, our panelists connect clinical evidence, updated labeling, and real-world experiences to help you understand where inhaled insulin fits in today’s treatment landscape.
This event is supported by MannKind Corporation.
Workshop Highlights
- Topic: From Evidence to Experience: What We’ve Learned About Inhaled Insulin
- Date & Time: Tuesday, 11 November, at 16:00 CET
- Duration: 1 Hour
- Speakers: Dr. David Ahn, Dr. Thomas Blevins and Assoc. Prof. Nouran Yousef
Don’t miss this opportunity to gain practical insights and clinical pearls from leading experts.
Moderator
Assoc. Prof. Nouran Yousef
Assistant Professor of Pediatric Diabetes, Endocrinology & Metabolism, Ain Shams University
Prof. Nouran Yousef is a clinician and researcher specializing in pediatric diabetes, endocrinology, and obesity. Based in Egypt, she has authored over 30 publications and serves as a reviewer for leading international journals. Her work focuses on diabetes technology, obesity, and equitable access to care.
Speakers
Dr. David Ahn
Endocrinologist & Program Director, Mary and Dick Allen Diabetes Center, Hoag Hospital
Dr. David Ahn is an endocrinologist specializing in diabetes and metabolism. He leads diabetes services at Hoag and previously served as an Assistant Clinical Professor at UCLA. His interests include diabetes technology and empowering patients to achieve better glucose control with less burden.
Dr. Thomas Blevins, MD, FACE, FNLA
Founder, Texas Diabetes & Endocrinology
Dr. Thomas Blevins founded Texas Diabetes & Endocrinology to advance diabetes, thyroid, and osteoporosis care in Central Texas. A Baylor College of Medicine graduate, he has dedicated his career to integrating the latest innovations in endocrinology into clinical practice.